fifty-two patients with stage iii or iv nodular mixed lymphocytic-histiocytic lymphoma ( nm ) were entered on a prospective randomized trial comparing cyclophosphamide-prednisone ( cp ) to either copp ( cyclophosphamide , vincristine , procarbazine , prednisone ) or bcvp ( bcnu , cyclophosphamide , vincristine , prednisone ) .
C0280003
cyclophosphamide-prednisone
C0032952
prednisone